🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

28 recruiting trials

for Human Papillomavirus Type 16

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer NCT07290621Phase 21 site📍 Chicago University of Chicago · Tests: Toripalimab, Carboplatin, Paclitaxel Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) NCT07209189Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Toripalimab + Chemotherapy, Toripalimab, Chemoradiotherapy or radiation A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer NCT06319963Phase 1, Phase 24 sites📍 Orlando📍 Tampa📍 Tampa Theravectys S.A. · Tests: Two IM injections Lenti-HPV-07, One IM injection Lenti-HPV-07 Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine NCT05371353n/a2 sites📍 Yangchun📍 Mianyang Shanghai Bovax Biotechnology Co., Ltd. PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia NCT07454915Phase 210 sites📍 The Bronx📍 Kaohsiung📍 Taichung PapiVax Biotech, Inc. · Tests: PVX4 Combination Product, Placebo Control Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination NCT07407569Phase 23 sites📍 Antwerp📍 Ghent📍 Leuven Universiteit Antwerpen · Tests: Gardasil 9 (2 dose regimen) Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT04422366Phase 31 site📍 Liuzhou Shanghai Bovax Biotechnology Co., Ltd. · Tests: 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha), GARD… CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs NCT07172256Phase 21 site📍 New Haven Yale University · Tests: CUE-101, Pembrolizumab Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors NCT07081984Phase 11 site📍 Shanghai Therorna · Tests: therapeutic tumor vaccine Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection NCT07306247NA5 sites📍 Hangzhou📍 Hangzhou📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: ALA-PDT Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL NCT07175662Phase 25 sites📍 Beijing📍 Beijing📍 Beijing Newish Biotech (Wuxi) Co., Ltd. · Tests: NWRD08 administered by electroporation, Placebo administered by electroporation Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer NCT07281599NA3 sites📍 New Haven📍 Minneapolis📍 Akron Qurasense · Tests: Q-Pad hrHPV Test System Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer NCT06589609Phase 11 site📍 Vienna BlueSky Immunotherapies GmbH · Tests: FluBHPVE6E7 A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region NCT07710664Phase 11 site📍 Beijing Newish Biotech (Wuxi) Co., Ltd. · Tests: NWRD09 NWRD09 for HPV-16 Related Cervical HSIL NCT07047989Phase 11 site📍 Beijing Newish Biotech (Wuxi) Co., Ltd. · Tests: NWRD09 injection Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ NCT06210854Phase 22 sites📍 Birmingham📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: pBI-11 (3 doses), pBI-11 (1 dose), Placebo (2 doses) E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226Phase 23 sites📍 Bethesda📍 New Brunswick📍 New Brunswick Christian Hinrichs · Tests: E7 TCR-T cells, Aldesleukin A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) NCT05334706Phase 41 site📍 L'Hospitalet de Llobregat Miquel Angel Pavon Ribas · Tests: Nonavalent HPV vaccine (9vHPV/Gardasil-9™). Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma NCT06016920Phase 1, Phase 212 sites📍 Montpellier📍 Paris📍 Giessen Nykode Therapeutics ASA · Tests: VB10.16, Pembrolizumab Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma NCT04852328Phase 21 site📍 St Louis Washington University School of Medicine · Tests: CUE-101 SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers NCT05582122Phase 216 sites📍 Saint-Denis📍 Avignon📍 Dijon UNICANCER · Tests: HPV16 Ct-DNA dosing Study of Treatment for HPV16+ ASC-US or LSIL NCT03913117Phase 12 sites📍 Birmingham📍 Baltimore University of Alabama at Birmingham · Tests: pNGVL4aCRTE6E7L2, TA-CIN PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer NCT05581121Phase 337 sites📍 Ostrava📍 Pilsen📍 Prague Institut Claudius Regaud · Tests: Standard treatment: Control arm, Experimental arm Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli) NCT07668271Phase 41 site📍 Zhangping Xiamen Innovax Biotech Co., Ltd · Tests: 9-valent HPV vaccine (Cecolin 9) A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. NCT06797986Phase 1, Phase 22 sites📍 Seoul📍 Seoul Cellid Co., Ltd. · Tests: BVAC-E6E7 (low level), BVAC-E6E7 (high level), BVAC-E6E7 (RP2D) Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women NCT05829629Phase 11 site📍 Bratislava BlueSky Immunotherapies GmbH · Tests: FluBHPVE6E7, Placebo NWRD09 for Persistent Cervical HPV16 Infection NCT07710703NA1 site📍 Beijing Newish Biotech (Wuxi) Co., Ltd. · Tests: NWRD09/ Placebo administered by IM injection HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia NCT04131413Phase 12 sites📍 Birmingham📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: pNGVL4aCRTE6E7L2
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy